387 related articles for article (PubMed ID: 28101568)
1. Puerarin inhibits M2 polarization and metastasis of tumor-associated macrophages from NSCLC xenograft model via inactivating MEK/ERK 1/2 pathway.
Kang H; Zhang J; Wang B; Liu M; Zhao J; Yang M; Li Y
Int J Oncol; 2017 Feb; 50(2):545-554. PubMed ID: 28101568
[TBL] [Abstract][Full Text] [Related]
2. Bu Fei Decoction attenuates the tumor associated macrophage stimulated proliferation, migration, invasion and immunosuppression of non-small cell lung cancer, partially via IL-10 and PD-L1 regulation.
Pang L; Han S; Jiao Y; Jiang S; He X; Li P
Int J Oncol; 2017 Jul; 51(1):25-38. PubMed ID: 28534943
[TBL] [Abstract][Full Text] [Related]
3. Astragaloside IV inhibits lung cancer progression and metastasis by modulating macrophage polarization through AMPK signaling.
Xu F; Cui WQ; Wei Y; Cui J; Qiu J; Hu LL; Gong WY; Dong JC; Liu BJ
J Exp Clin Cancer Res; 2018 Aug; 37(1):207. PubMed ID: 30157903
[TBL] [Abstract][Full Text] [Related]
4. Modulation the crosstalk between tumor-associated macrophages and non-small cell lung cancer to inhibit tumor migration and invasion by ginsenoside Rh2.
Li H; Huang N; Zhu W; Wu J; Yang X; Teng W; Tian J; Fang Z; Luo Y; Chen M; Li Y
BMC Cancer; 2018 May; 18(1):579. PubMed ID: 29783929
[TBL] [Abstract][Full Text] [Related]
5. Anti-proliferation and anti-metastasis effect of barbaloin in non-small cell lung cancer via inactivating p38MAPK/Cdc25B/Hsp27 pathway.
Zhang Z; Rui W; Wang ZC; Liu DX; Du L
Oncol Rep; 2017 Aug; 38(2):1172-1180. PubMed ID: 28656293
[TBL] [Abstract][Full Text] [Related]
6. [Macrophage colony stimulating factor enhances non-small cell lung cancer invasion and metastasis by promoting macrophage M2 polarization].
Li YJ; Yang L; Wang LP; Zhang Y
Zhonghua Zhong Liu Za Zhi; 2017 Jun; 39(6):412-418. PubMed ID: 28635229
[No Abstract] [Full Text] [Related]
7. Effects of IFN-γ on the immunological microenvironment and TAM polarity in stage IA non-small cell lung cancer and its mechanisms.
Zhao W; Wang H; Zhang X; Zhang L; Pu W; Ma Y; Chen W
BMC Pulm Med; 2024 Jan; 24(1):46. PubMed ID: 38254043
[TBL] [Abstract][Full Text] [Related]
8. HHLA2 deficiency inhibits non-small cell lung cancer progression and THP-1 macrophage M2 polarization.
Sun W; Li S; Tang G; Sun S; Luo Y; Bai R; Han L; Jiang X; Gao Y; Huang Z; Zhang J; Gong Y; Xie C
Cancer Med; 2021 Aug; 10(15):5256-5269. PubMed ID: 34152094
[TBL] [Abstract][Full Text] [Related]
9. Cisplatin resistant lung cancer cells promoted M2 polarization of tumor-associated macrophages via the Src/CD155/MIF functional pathway.
Huang WC; Kuo KT; Wang CH; Yeh CT; Wang Y
J Exp Clin Cancer Res; 2019 Apr; 38(1):180. PubMed ID: 31036057
[TBL] [Abstract][Full Text] [Related]
10. Comprehensive Integrative Analysis Reveals the Association of
Arora S; Singh P; Ahmad S; Ahmad T; Dohare R; Almatroodi SA; Alrumaihi F; Rahmani AH; Syed MA
Cells; 2021 Aug; 10(8):. PubMed ID: 34440860
[TBL] [Abstract][Full Text] [Related]
11. Tumor hypoxia enhances Non-Small Cell Lung Cancer metastasis by selectively promoting macrophage M2 polarization through the activation of ERK signaling.
Zhang J; Cao J; Ma S; Dong R; Meng W; Ying M; Weng Q; Chen Z; Ma J; Fang Q; He Q; Yang B
Oncotarget; 2014 Oct; 5(20):9664-77. PubMed ID: 25313135
[TBL] [Abstract][Full Text] [Related]
12. Inactivation of M2 AChR/NF-κB signaling axis reverses epithelial-mesenchymal transition (EMT) and suppresses migration and invasion in non-small cell lung cancer (NSCLC).
Zhao Q; Yue J; Zhang C; Gu X; Chen H; Xu L
Oncotarget; 2015 Oct; 6(30):29335-46. PubMed ID: 26336823
[TBL] [Abstract][Full Text] [Related]
13. Gefitinib inhibits M2-like polarization of tumor-associated macrophages in Lewis lung cancer by targeting the STAT6 signaling pathway.
Tariq M; Zhang JQ; Liang GK; He QJ; Ding L; Yang B
Acta Pharmacol Sin; 2017 Nov; 38(11):1501-1511. PubMed ID: 29022575
[TBL] [Abstract][Full Text] [Related]
14. Pyropia yezoensis glycoprotein promotes the M1 to M2 macrophage phenotypic switch via the STAT3 and STAT6 transcription factors.
Choi JW; Kwon MJ; Kim IH; Kim YM; Lee MK; Nam TJ
Int J Mol Med; 2016 Aug; 38(2):666-74. PubMed ID: 27353313
[TBL] [Abstract][Full Text] [Related]
15. 13-Methyl-palmatrubine shows an anti-tumor role in non-small cell lung cancer via shifting M2 to M1 polarization of tumor macrophages.
Wu Z; Zhou J; Chen F; Yu J; Li H; Li Q; Li W
Int Immunopharmacol; 2022 Mar; 104():108468. PubMed ID: 35066343
[TBL] [Abstract][Full Text] [Related]
16. Atractylenolide II inhibits tumor-associated macrophages (TAMs)-induced lung cancer cell metastasis.
Zhang Y; Liu Y; Wang J; Jiang Z; Zhang L; Cui Y; Zhao D; Wang Y
Immunopharmacol Immunotoxicol; 2022 Apr; 44(2):227-237. PubMed ID: 35166628
[TBL] [Abstract][Full Text] [Related]
17. Marsdenia tenacissima extract disturbs the interaction between tumor-associated macrophages and non-small cell lung cancer cells by targeting HDGF.
Fu JL; Hao HF; Wang S; Jiao YN; Li PP; Han SY
J Ethnopharmacol; 2022 Nov; 298():115607. PubMed ID: 35973634
[TBL] [Abstract][Full Text] [Related]
18. Antitumor and antimetastatic actions of dihydroxycoumarins (esculetin or fraxetin) through the inhibition of M2 macrophage differentiation in tumor-associated macrophages and/or G1 arrest in tumor cells.
Kimura Y; Sumiyoshi M
Eur J Pharmacol; 2015 Jan; 746():115-25. PubMed ID: 25445053
[TBL] [Abstract][Full Text] [Related]
19. Tumoral NOX4 recruits M2 tumor-associated macrophages via ROS/PI3K signaling-dependent various cytokine production to promote NSCLC growth.
Zhang J; Li H; Wu Q; Chen Y; Deng Y; Yang Z; Zhang L; Liu B
Redox Biol; 2019 Apr; 22():101116. PubMed ID: 30769285
[TBL] [Abstract][Full Text] [Related]
20. Puerarin inhibits non-small cell lung cancer cell growth via the induction of apoptosis.
Hu Y; Li X; Lin L; Liang S; Yan J
Oncol Rep; 2018 Apr; 39(4):1731-1738. PubMed ID: 29393465
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
